Skip to content
To the full analysis

Neurogene stock: balance sheet and debt

NGNE
$23.90Closing price of 12 Nov 2026MEQIRI Score 32 out of 100

Neurogene has a debt to equity ratio of 0.04.

Daily figure as of 13 Nov 2026

Debt / Equity
0.04
Interest coverage
−50x
Current ratio
16.56
Cash & equivalents
$269.01M
Total assets
$288.6M
Equity ratio
91.8%
Goodwill
not reported separately
Net debt
−$259.12M
More cash than debt

Total assets and equity ratio

How large the balance sheet of Neurogene Inc. is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2011$9.88M$108.02Knot split out86.9%−$9.24M
2012$2.34M$85.26Knot split out37.3%−$2M
2013$58.77M$62.51Knot split out87.3%−$54.66M
2014$41.42Mnot reported separatelynot reported separately87.3%−$39.02M
2015$113.34Mnot reported separatelynot reported separately95.7%−$74.35M
2016$154.38Mnot reported separatelynot reported separately93.7%−$103.01M
2017$110.33Mnot reported separatelynot reported separately89.6%−$108.05M
2018$77.62Mnot reported separatelynot reported separately93.6%−$76.92M
2019$147.02M$567Knot split out96.4%−$141.88M
2020$210.52M$347Knot split out90.8%−$180.43M
2021$101.49M$128Knot split out−90.5%−$64.11M
2022$109.27Mnot reported separatelynot reported separately90.3%−$77.33M
2023$222.57Mnot reported separatelynot reported separately83.6%−$180.9M
2024$335.73Mnot reported separatelynot reported separately92.4%−$299.98M
2025$288.6Mnot reported separatelynot reported separately91.8%−$259.12M

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2011$9.24M$8.59M$00
2012$2M$874.03K$00
2013$56.95M$51.28M$2.29M0.04
2014$39.1M$36.15M$72.34K0
2015$74.48M$108.42M$131K0
2016$103.06M$144.66M$47K0
2017$108.09M$98.89M$33K0
2018$76.93M$72.67M$6K0
2019$143.09M$141.69M$1.21M0.01
2020$192.56M$191.22M$12.12M0.06
2021$70.54M−$91.88M$6.43M−0.07
2022$82.02M$98.63M$4.69M0.05
2023$197.16M$186.02M$16.26M0.09
2024$312.41M$310.38M$12.43M0.04
2025$269.01M$264.89M$9.89M0.04

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 31 Mar 2015)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy